Substrate inhibition was observed with the heterodimeric (p66/pSi) and the homodimeric (p66/p66, p5i/p5i) forms of human immunodeficiency virus type 1 reverse transcriptase (RNA-dependent DNA polymerase, EC 2.7.7.49). An apparent K; value of 195 ± 37 1LM was determined for dTTP using the bacterial cloned and expressed heterodimer. Similar values were obtained with the homodimeric and the virus-encoded enzymes. When poly-(rC)-p(dG)1o was used as template-primer, dGTP exhibited substrate inhibition with an apparent K; value of 189 ± 32 #tM.
The reverse transcriptase (RNA-dependent DNA polymerase, EC 2.7.7.49, RT) encoded by the human immunodeficiency virus type 1 (HIV-1) is essential for the replication of HIV-1. Like the RT of other retroviruses, HIV-1 RT catalyzes the synthesis of a duplex DNA copy of the singlestranded viral RNA genome. The native enzyme isolated from virus cores is composed of two asymmetric subunits of molecular mass 66,000 daltons (p66) and 51,000 daltons (p5l) (1, 2) . The p66 subunit possesses a polymerase and an RNase H domain, whereas the p51 subunit, generated through C-terminal proteolysis of p66, contains only the polymerase domain (3) (4) (5) . HIV-1 RT purified from bacterial expression systems appears to have identical chemical and physical properties to that isolated from virions (6, 7) .
A bireactant-biproduct mechanism, similar to the mechanism described for other DNA polymerases, has been proposed for HIV-1 RT-catalyzed DNA synthesis (8) . In this mechanism, the reaction proceeds in an ordered fashion: template-primer binding is followed by the binding of 2'-deoxynucleoside 5'-triphosphate (dNTP) (8) . Substrate inhibition is a phenomenon whereby high concentrations of a substrate can inhibit its own conversion to product. A characteristic feature of substrate inhibition is a decrease in the velocity of the reaction at higher substrate concentrations.
We report that HIV-1 RT is inhibited by high concentrations of the natural dNTP substrates of the polymerase reaction. Our studies suggest that a secondary, low-affinity binding site for substrate may exist in the Michaelis complex, either within or near the catalytic site. Understanding the nature of this second site could prove useful in the design of new inhibitors of this enzyme and of HIV-1.
MATERIALS AND METHODS
Chemicals and Reagents. Poly(rA) oligo(dT)1o, poly-(rC)'oligo(dG)12_18, poly(dA)-p(dT)1o, and the ultrapure tetrasodium salts ofdTTP, dGTP, and dATP were purchased from Pharmacia LKB. The purity of the dNTPs was judged by 31p and 1H NMR, by ion-exchange FPLC, and by HPLC analysis to be >99%. Thymidine Enzyme Purification. Heterodimeric HIV-1 RT (p66/p5i) was expressed in Escherichia coli using mpRT4 as the expression vector (kindly provided by Brendan Larder) and was purified by immunoaffinity column chromatography (7, 9, 10) . Packed cells (50 g of wet weight) were resuspended at 4°C in 100 ml of buffer A (50 mM Tris'HCI, pH 7.8/1 mM EDTA/5 mM 2-mercaptoethanol/0.1 mM phenylmethylsulfonyl fluoride/10 ,ug each of soybean trypsin inhibitor, leupeptin, and aprotinin per ml). Lysozyme (100 mg) was added to the resuspended cells and the mixture was incubated at 37°C for 30 min. The lysed cells were sonicated and then centrifuged at 12,000 x g for 20 min. The pellet, which contained 80% of the RT activity, was resuspended in buffer A and made 1 M with NaCl. Three cycles of sonication followed by centrifugation were required to release enzym'" activity. The supernatants from each cycle were combined] and ammonium sulfate precipitated. The fraction precipitated by 30-65% saturated ammonium sulfate was collected, dialyzed against 50 mM Tris HCI (pH 8.0), and then applied to an FPLC preparative mono Q anion-exchange column equilibrated with the same buffer. Enzyme was eluted from the column with a 0-1 M NaCl gradient in 50 mM Tris-HCI (pH 8.0). Fractions that eluted at 200 mM NaCl and contained the HIV-1 RT were pooled and dialyzed against 50 mM Tris-HCI, pH 8.8/100 mM NaCl. The HIV-1 RT was applied to an immunoaffinity column (7, 10, 11) and eluted with 1 M Nal. Fractions containing the HIV-1 RT were collected, dialyzed against 50 mM Tris (pH 7.6), and stored at -70°C. The protein was >98% pure as judged by silver-stain SDS/PAGE and consisted of approximately equimolar proportions of p51 and p66. Homodimeric p51 RT was produced in E. coli using pCTR1 as the expression vector (kindly provided by Margret Tisdale) and was purified as described (9, 10) . The purified Abbreviations: RT, reverse transcriptase; HIV-1, human immunodeficiency virus type 1; FIV, feline immunodeficiency virus; AMV, avian myeloblastosis virus.
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protein was >95% pure and contained no detectable amounts of p66 homodimer. Homodimeric p66 RT was produced in E. coli using mpRT4 as the expression vector and purified as described by Cheng et al. (10) . The purified p66 was >90%o pure. Virus-associated RT was prepared for enzyme assays by incubating purified HIV-1 in 50 mM Tris, pH 7.6/5 mM MgCl2/0.05% Nonidet P-40 at 40C for 1 hr prior to performing the assay.
Enzyme Assays. HIV-1 RT was assayed as described (10) . Unless otherwise indicated, the standard reaction mixture (150 td) contained 50 mM Tris (pH 7.6), 5 mM MgCI2, 70 tug of template-primer per ml, and dNTP substrates at the indicated concentrations. Reactions were performed at 370C and started by the addition of 0.2 ,ug of enzyme. Single incorporation kinetics for the turnover of dTTP were performed using a 20/A40-mer and a r44/d21-mer as the template-primer. The sequence of the 20-mer was 5'-CGC-ACC-GAG-CCA-CGA-CAG-GC-3'. The sequence of the 40-mer was 5'-GGT-GTA-TAA-CTA-GGT-AGC-TAG-CCT-GTC-GTG-GCT-CGG-TGC-G-3'. Before use, the oligonucleotides were dissolved in 50 mM Tris, pH 7.6/100 mM KCI at a concentration of 12.5 uM with respect to 5' ends. The oligonucleotides were mixed in a 1:1 molar ratio and were annealed by heating to 65°C for 15 min and then cooling to room temperature. The r44/d21-mer was a generous gift from John Reardon, the sequence of which is 3'-CCC-CUA-GGA-GAU-CUC-AGC-UGG-ACG-UCC-GUA-CGU-UCG-AAC-AGA-GG-5' for the r44-mer and 5'-GGG-GAT-CCT-CTA-GAG-TCG-ACC-3' for the d21-mer (11) . Reaction rates were linear over the course of the experiments. Apparent Km and Ki values were determined using the computer program published by Cleland (12) .
Fluorescence Binding Assays. Steady-state fluorescence was measured using a Perkin-Elmer MPF-66 spectrofluorometer operating in the ratio mode. Fluorescence intensities of the enzyme were corrected for optical filtering effects due to additions of nucleotide. Corrections were generally <20%o. Titrations were carried out by adding 5-to 10-.ul samples of a 1 mM solution of either dTTP or dGTP to a 5 nM solution of HIV-1 RT saturated with template-primer in standard assay buffer and monitoring the change in fluorescence, AF, at 344 nm. Excitation ofthe protein was carried out at 290 nm. Kd values were determined from a nonlinear least-squares regression analysis of the titration data using Eq. 1,
and the appropriate dNTP substrate, have exhibited linear Lineweaver-Burk plots. However, as seen in Fig. 1 Inset, increasing the concentration of dNTP above 50 ,M resulted in a marked decrease in the velocity of the reaction. When these data were plotted in double-reciprocal form ( Fig. 1 ), the resulting curve showed an upward deflection at high substrate concentrations. This pattern has been shown to be indicative of substrate inhibition. Identical experiments were performed with the p66 and p51 homodimeric forms of the enzyme. As with the p66/pSi heterodimer, substrate inhibition was observed for dTTP with the p66/p66 and the p51/pSi homodimeric forms (see below and Table 1 ). To ensure that substrate inhibition was not an artifact of the cloned enzyme, identical experiments were performed using Nonidet P-40-disrupted HIV-1 as the source of enzyme. The results of this experiment (see below and Table 1 ) confirm that substrate inhibition also occurs with the authentic virus-encoded enzyme.
To determine whether substrate inhibition is a general feature of RTs, we assayed the RTs of AMV and FIV for substrate inhibition. Under the same assay conditions employed for the HIV-1 RT, substrate inhibition was not obvious with AMV RT at concentrations of dTTP up to 600 ,uM. Substrate inhibition of FIV RT, although obvious, was not as strong as with HIV-1 RT (see below and [3] From this analysis, apparent Km and K, values of 6.6 ± 0.5 ,uM and 195 ± 37 ,uM, respectively, were determined for dTTP using the bacterially expressed p66/pSl heterodimer (Table 1) . Similar values were obtained with the authentic viral enzyme (Table 1 ). The apparent Km and Ki values obtained for dTTP with the p66 and the pSi homodimers were [1] where AFmax is the change in fluorescence at infinite concentration of dNTP and [dNTP]tot is the total dNTP concentration (13 [2] where n is the number of dNTP binding sites per heterodimer and K is the concentration of dNTP that yields 50% of AFma,.
Photoaffinity Labeling. The crosslinking of [y-32P]dTTP to HIV-1 RT was performed as described by Cheng et al. (10 Table 1 ). The apparent K1 values for substrate appear to be independent of the concentration of template-primer, as exemplified by the case of dTTP, in which the concentration of poly(rA)-p(dT)1O was varied from 0.1 to 20 times the Km (5 ,ug/ml) with no effect on K1 (data not shown).
Specificity of Substrate Inhibition. To determine the specificity of substrate inhibition, we examined the effect of increasing concentrations of a noncomplementary substrate on incorporation of dTTP into poly(rA)-p(dT)10. At a fixed concentration of dTTP (20 AuM), where substrate inhibition is not a factor, noncomplementary substrates at concentrations of up to 1 mM did not inhibit enzyme activity (Table 2) . Furthermore, the ribonucleoside triphosphate, ATP, did not affect enzyme activity at a concentration of 1 mM (Table 2) . Thymidine, although complementary to the template strand of poly(rA)-p(dT)10, did not inhibit enzyme activity at concentrations of 1.0 mM (Table 2) . When poly(dA).p(dT)1O was used as template-primer and dTTP was used as substrate, substrate inhibition by dTTP was not apparent at concentrations up to 400 ,uM ( Fig. 2A) . The apparent Km for dTTP when poly(dA) p(dT)1O was used as template-primer was 5.8 ± 0.8 ,uM. When saturating levels of the 20/A40-mer DNADNA template-primer were used in a single turnover reaction where dTTP was the only substrate present, no substrate inhibition was observed (Fig. 2B ) and a Km of 23.1 ,uM was determined for dTTP. However, when the r44/d21-mer RNA-DNA template-primer was used in the single turnover reaction, substrate inhibition was observed (Fig. 2C) . The apparent K, value for dITP was 117 ± 27 ,uM and the apparent Km value for dTTP was 0.09 ± 0.007 ,M.
Hill Plots and the Stoichiometry of Binding. The heterodimeric form of HIV-1 RT contains 36 tryptophan residues, including one (W266) adjacent to the putative dNTP binding site (14) . The tryptophan residues provide an intense fluorescence emission peak with a Ama, at 338 nm (13) . The interaction of dNTPs with enzyme saturated with templateprimer results in a decrease in the fluorescence intensity of the enzyme, AF, which can be used to calculate Kd values (see Eq. 1, Materials and Methods). The stoichiometry of dNTP binding was determined by replotting the titration data Photoaffinity Labeling with [r-32P]dTTP. Site-specific photochemical crosslinking to proteins, including the HIV-1 RT, has been used to identify those segments of the protein involved in nucleic and nucleotide binding (10, 15, 16) . The results of UV-induced crosslinking reactions using increasing concentrations of [32P]dTrP are shown in Fig. 4 (8) . If the dNTP is complementary to the next available base in the template, the ternary complex undergoes isomerization to form the active complex. Since the reactant binding and dissociation steps are believed to be rapid relative to the isomerization step (8) , addition of dNTP to enzyme saturated with template-primer would lead to the buildup of a transitory ternary complex (E-TP-dNTP). Given this quasiequilibrium condition, the Kd values and Hill coefficients calculated from the data in Fig.   3 report the stability and the stoichiometry of this ternary complex. There is no indication from the Hill plots in Fig. 3 or from the photoaffinity labeling experiments (Fig. 4) of the existence of a second low-affinity dNTP binding site in this ground state complex. It is our belief that this second site is created in or near the active site by the isomerization of the E-TP-dNTP ternary complex to form the active complex. At the concentration of dNTP used in this study, substrate inhibition is only apparent when an RNADNA templateprimer is used, suggesting that there is a difference in the configuration of the active complex depending on whether the template is RNA or DNA.
The work of Merluzzi et al. (19) and Pauwels et al. (20) also suggests the existence of a second binding site in HIV-1 RT.
These authors described the nonnucleoside inhibitors BI-RG-587 (19) and TIBO (20) 
